课题基金 / 基金详情

PHASE IV AI: Privacy Compliant Health Data As A Service For AI Development

PHASE IV AI: Privacy Compliant Health Data As A Service For AI Development
第四阶段人工智能:符合隐私的健康数据作为人工智能开发的服务
批准号:
10078953
负责人:
金额:
$61.85万
依托单位:
依托单位国家:
英国
项目类别:
EU-Funded
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Artificial intelligence (AI) enables data-driven innovations in health care. AI systems, which process vast amounts of data quickly and in detail, show promise both as a tool for preventive health care and clinical decision-making. However, the distributed storage and limited access to health data form a barrier to innovation, as developing trustworthy AI systems requires large datasets for training and validation. Furthermore, the availability of anonymous datasets would increase the adoption of AI-powered tools by supporting health technology assessments and education. Secure, privacy compliant data utilization is key for unlocking the full potential of AI and data analytics. In this proposal, we will advance the current state-of-the-art data synthesis methods towards a more generalized approach of synthetic data generation. We will also develop metricsfor testing and validation, as well as protocolsthat enable synthetic data generation without access to real-world data (through multi-party computation). We aim to provide: 1) Improved methods and technical pipelinesfor privacy-preserving data synthesis including different data formats such as EHRs and medical images, 2) Easy to use and configurable data servicesto enable AI developers’ accessto larger pools of decentralized de-identified data through multi-party computing, 3) Provide anonymous data on demand or from a (temporary) repository, 4) Establish a Data Market – facilitating data sharing and monetization incl. incentives-based provision of data to the services, 5) Integrate the data market and the data service ecosystem as a X-European health data hub in the European Health Data Space, and 6) Validate the results with real-world use-cases focusing on high impact diseases, cancer types in particular.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
NNMT甲基化修饰SIRT1调控肿瘤微环境T细胞线粒体功能够障碍从而影响H IV相关结直肠癌的发展
靶向抑制FAP/DPP-IV双靶点的食源性活 性多肽挖掘及功能机制探究
产酶溶杆菌IV型效应蛋白Le1288淬灭柑橘溃疡病菌DSF信号分子的机制研究
  • 批准号:
    2025JJ60176
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    廖金星
  • 依托单位:
肺炎克雷伯菌IV型分泌系统Tra蛋白介导IncFII质粒传播的机制研究